Summit Therapeutics: Citigroup cuts target price to $42 from $43
SMMT•Citigroup cut its target price for Summit Therapeutics to $42 from $43.
Related News

Success Universe says Tesla shares made up its entire HK$257 million securities portfolio at end-2025
TSLA•

DTE Energy Company: Jefferies raises target price to $165 from $152
DTE•

Baidu quarterly revenue slips as advertising weakness overshadows AI demand
BIDU•

Bermaz Auto subsidiary Bermaz Xpeng ceases XPENG operations in Malaysia
XPEV•

Nasdaq trade halt continues, reason not available at 03:58 a.m.
DFSCW•